VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > The question becomes?

<< Previous

Bullboard Posts

Next >>

Comment by SirStocksalot97on Oct 29, 2020 5:30pm

139 Views

Post# 31810045

RE:RE:RE:RE:RE:RE:RE:RE:The question becomes?

As a CPA for 10+ years in public practice, I confirm that you are on the ball about this :). Although positive speculation helps us sleep at night, this is a bit of a long-shot tbh. One step at a time my old friend!

Looking forward to a future NR with 20+ units and growing progress in new hospitals before year end.

<< Previous

Bullboard Posts

Next >>

This junior mining stock offers billions in market exposure